Big Phar­ma R&D is ex­it­ing Chi­na, but leav­ing a lega­cy; Chi­na's biotech ex­ecs couldn’t be hap­pi­er

Bloomberg post­ed a sto­ry about the Big Phar­mas that have been bail­ing out of Chi­na re­cent­ly. We’ve been cov­er­ing this step by step at End­points News, but it’s worth point­ing out that the big out­fits that en­tered Chi­na with such fan­fare around 7 or 8 years ago ac­com­plished very lit­tle of note with their R&D groups. They did, how­ev­er, ef­fec­tive­ly train a whole gen­er­a­tion of ex­ecs who are play­ing a big role in mak­ing the Asian gi­ant a big new play­er in bio­phar­ma. That may not have been the pay­back they were look­ing for, but it is sig­nif­i­cant.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.